Mr. Ben Nikolaevsky of Pure Extracts reports
PURE EXTRACTS AND CANADA HOUSE WELLNESS GROUP SIGN AGREEMENT TO DISTRIBUTE CONCENTRATE PRODUCTS THROUGH EXISTING PROVINCIAL DISTRIBUTION CHANNELS
Pure Extracts Technologies Corp. and Canada House Wellness Group Inc. have entered into a cannabis 2.0 distribution agreement. Under the terms of the agreement, Canada House's wholly owned subsidiary, Abba Medix Corp., will distribute Pure Extracts' line of concentrate products through its established provincial distribution channels.
"We've been extremely impressed with the Pure Extracts team and the brand presence they have established, particularly in the western provinces, and are looking forward to supporting their commercialization efforts in a mutually beneficial way," commented Chris Churchill-Smith, Canada House chief executive officer.
Pure Extracts' chief executive officer, Ben Nikolaevsky, added, "This agreement allows us to quickly and efficiently get our outstanding line of full-spectrum oil vape and edible products to retail buyers across Canada while our sales amendment application is being processed by Health Canada."
About Pure Extracts Technologies Corp.
The company features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, B.C. The bespoke facility has been constructed to European Union GMP (good manufacturing practice) standards aiming toward export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions, where they are legally available. On Sept. 25, 2020, Pure Extracts was granted its standard processing licence by Health Canada under the Cannabis Act, and the company's stock began trading on the Canadian Securities Exchange (CSE) on Nov. 5, 2020.
About Canada House Wellness Group Inc.
Canada House Wellness Group is the parent company of Abba Medix, a licensed producer in Pickering, Ont., that produces high-quality medical-grade cannabis; IsoCanMed Inc., a licensed producer in Louiseville, Que., growing best-in-class indoor cannabis, in its 64,000-square-foot production facility, employing state-of-the-art vertical, aeroponic, production methodologies; Canada House Clinics Inc., with clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider and patient to data that support treatment with medical cannabis.
Canada House Wellness Group's goal is to become the leading cultivator of premium craft cannabis and provider of cannabinoid therapy, targeting the medical cannabis markets globally.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.